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492Exploration of the mechanisms by which
3,4-benzopyrene promotes angiotensin II-induced
abdominal aortic aneurysm formation in mice
Kangting Ji, MD,a Yong Zhang, PhD,a Fengchun Jiang, MD,a Lu Qian, MD,a Huihui Guo, MD,a
Jianjian Hu, MD,a Lianming Liao, PhD,b and Jifei Tang, MD, PhD,a Wenzhou and Fuzhou, China
Objective: This study examined the inﬂuence of 3,4-benzopyrene (BaP), a compound found in cigarette smoke, on the
formation of angiotensin II (Ang II)-induced abdominal aortic aneurysm (AAA) formation in mice and the underlying
mechanisms.
Methods: C57/B6n mice were divided into four groups. The control group received a weekly intraperitoneal injection of
medium-chain triglycerides. The Ang II group received a daily Ang II infusion (0.72 mg/kg) and a weekly intraperitoneal
injection of medium-chain triglycerides. The Ang II/BaP group received a daily Ang II infusion (0.72 mg/kg) and a
weekly intraperitoneal BaP injection (10 mg/kg, dissolved in medium-chain triglycerides). The BaP group received
a weekly intraperitoneal BaP injection (10 mg/kg). After 5 weeks, abdominal aortic diameter was determined. Aortic
tissues underwent hematoxylin and eosin, Masson, and immunochemistry staining for evaluation of vascular wall
structure, collagen, macrophage inﬁltration, matrix metalloproteinases (MMPs), and apoptosis.
Results: The Ang II infusion and BaP injection induced AAAs in 41.67% of mice vs 25% in the Ang II group (P < .05). The
average aortic diameter increased in the Ang II/BaP group compared with the Ang II group (1.40 6 0.25 vs 1.2 6
0.23 mm; P < .05). Average aortic muscular cell apoptosis was higher in the Ang II/BaP group (31% 6 12%) than in the
Ang II (19% 6 5%; P < .05) or BaP groups (23% 6 4%; P < .05). Aortic macrophage inﬁltration and expression of
MMP-2, MMP-9, MMP-12, and nuclear factor-kB increased (0.56 6 0.12, 0.47 6 0.13, 0.49 6 0.14, 0.49 6 0.11, and
0.42 6 0.12, respectively) in the Ang II/BaP group compared with the Ang II group (0.27 6 0.08, 0.25 6 0.06, 0.24 6
0.09, 0.24 6 0.09, and 0.23 6 0.06, respectively; P < .05 for all).
Conclusions: BaP promotes Ang II-induced AAA formation in mice via elevating inﬁltration of macrophages, activating
nuclear factor-kB, upregulating the expression of MMP-2, MMP-9, and MMP-12, and increasing the apoptosis of
vascular muscle cells in its synergistic effect with Ang II in aortic wall. (J Vasc Surg 2014;59:492-9.)
Clinical Relevance: Abdominal aortic aneurysm (AAA) is a potentially fatal condition for the adult population. Tobacco
smoking has long been considered to be a notorious risk factor for AAA. A key component of cigarette smoke is
3,4-benzopyrene. We demonstrate that 3,4-benzopyrene may contribute to the pathogenesis of AAA, thus providing new
evidence that tobacco is a risk factor for AAA.Abdominal aortic aneurysm (AAA) is a potentially fatal
condition in the adult population, and an estimated 1% to
3% of men aged 65 to 85 years die of AAA in developed
countries.1 Conventional treatments for AAA include
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is still not well understood, and basic and clinical research
on this disease is urgently needed to develop effective ther-
apeutic medications. Before effective treatments are avail-
able, prevention of AAA is critical to decrease AAA-related
morbidity and mortality. Although several risk factors have
been identiﬁed, the pathogenesis of AAA is still unclear.
Recent studies suggest inﬂammation, matrix metalloprotei-
nase (MMP) activation, and smooth muscle cell apoptosis
in human AAA are involved in the formation of AAA.2-6
Tobacco smoking has long been considered to be a
notorious risk factor for AAA.7 The risk of developing
AAA is eight times greater in smokers than in nonsmokers,
and the risk decreases when the individual quits smoking.8
Cigarette smoke contains components that contribute to
AAA formation, and one such key component is 3,4-
benzopyrene (BaP).9 The average intake of BaP is estimated
to bew700 ng/d for unﬁltered cigarettes or 400 ng/d for
ﬁltered cigarettes if the smoker consumes a pack of ciga-
rettes per day.10 At the same time, 6 to 10 mg polycyclic
aromatic hydrocarbons will be absorbed.11 BaP has been
shown to activate nuclear factor (NF)-kB in blood vessel
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pression of matrix metalloproteinases (MMPs),14 and in-
duce apoptosis of vascular muscle cells.15 Because each of
these processes is involved in AAA formation, we hypothe-
sized that BaP may contribute to the pathogenesis of AAA.
Zhang and Ramos16 previously demonstrated that BaP
indeed contributes to the development of AAA in the
murine angiotensin (Ang) II infusion model of AAA forma-
tion. In this model, infusion of Ang II at a low dose results
in AAA formation inw20% of these animals. However, the
mechanism by which BaP promotes the AAA formation has
yet to be clearly elucidated. Loss of vascular smooth muscle
cells (VSMCs) in media17,18 is a prominent phenomenon in
AAA. Although BaP has been reported to cause VSMC
apoptosis19 in vitro, studies have also showed that BaP
augments the growth of VSMCs.20 It would be interesting
to understand how BaP exerts its effect on VSMCs in an
in vivo setting.
The results in this study suggest that BaP may be in-
volved in the AAA formation through elevating inﬁltration
of macrophages, activating NF-kB, upregulating the expres-
sion of MMP-2, MMP-9, and MMP-12, and increasing
apoptosis of VSMCs in a synergistic way with Ang II.
METHODS
The Animal Care and Use Committee at the Wenzhou
Medical College approved the study. Animal care complied
with the Guide for the Care and Use of Laboratory Animals
(Institute of Laboratory Animal Resources, Commission
on Life Sciences, National Research Council, National
Academy Press, 1996; http://nap.edu/openbook.php?
record_id¼5140).
Experimental animals. Male C57/B6n mice, weigh-
ing 35 to 40 g and 7 to 9 months old (Weitonglihua
Experimental Animal Technology Co Ltd, Beijing, China),
were housed in a speciﬁc pathogen-free environment.
Water and normal diet were available ad libitum.
Mice were divided into four groups of 12 mice each.
Mice in the control group received a weekly intraperitoneal
injection of medium-chain triglycerides (Aabrafac lipophile
wl 1349; Gattefosse Co, Lyon, France). Mice in the Ang II
group received a daily Ang II (Sigma-Aldrich Co, St. Louis,
Mo) infusion (0.72 mg/kg) via a subcutaneous osmotic
minipump (Alzet Osmotic Pump, Model 2004; Durect
Corp, Cupertino, Calif) in addition to medium-chain
triglycerides.17,21 Mice in the BaP group received a weekly
intraperitoneal BaP (Sigma-Aldrich) injection (10 mg/kg).
Mice in the Ang II/BaP group received Ang II (0.72mg/kg)
and BaP (10 mg/kg). BaP was dissolved in medium-chain
triglycerides (2 mg/ml). After 5 weeks, mice were eutha-
nized. Aortic tissue was harvested and processed for histo-
logic studies.
Implantation of osmotic minipumps. Osmotic
minipumps were inserted subcutaneously, as previously
described.16
Aortic tissue collection and measurement. After
animals were euthanized, the abdominal and thoracic cavi-
ties were exposed, and the aorta was sequentially irrigatedwith phosphate-buffered saline (PBS) and 4% formalde-
hyde through the left ventricle. The periadventitial tissue
was carefully dissected away from the aorta wall under
a dissection microscope. The abdominal aorta tissue was
removed from the last intercostal artery to the ileal bifur-
cation and ﬁxed in 4% paraformaldehyde for immunohis-
tochemistry. For each specimen, at least 12 aortic sections
were selected and diameters determined after hematoxylin
and eosin staining. The average diameter was calculated.
AAA was deﬁned as $50% enlargement of average aorta
diameter.17
Immunochemistry staining. Sections of abdominal
aorta (4 mm thick) were deparafﬁnized and rehydrated. A
laboratory microwave was used for high-temperature
antigen retrieval. To quench endogenous peroxidase
activity, the tissue sections were incubated in 3% hydrogen
peroxide in methanol for 10 minutes. The histologic
sections were respectively immunostained with speciﬁc
monoclonal antibodies against cluster of differentiation 68,
MMP-2, MMP-9, MMP-12, and NF-kB (all from Bio-
synthesis Biotechnology Co Ltd, Beijing, China). Cluster
of differentiation 68 served as a marker for macrophages.
As a negative control, PBS was used to replace the pri-
mary antibody. The secondary monoclonal antibody was
then added and visualized with horseradish peroxidase/
diaminobenzidine (ZSGB Biotechnology Co Ltd, Beijing,
China), which was brown or dark brown. Each image was
collected by an investigator, who was blinded to sample
identity, using identical microscope settings. The results of
immunostaining were semiquantiﬁed by densitometric
analysis using the IPP software (Adobe).
Masson’s trichrome staining. Collagen distribution
in the aortic wall was evaluated by Masson staining. Brieﬂy,
aortas were ﬁxed in formalin solution (neutral buffered,
10%), and embedded in parafﬁn. Sections (4 mm) were
dewaxed and rehydrated, followed by counterstaining
with Weigert’s iron hematoxylin (5-10 minutes), followed
by Masson’s trichrome staining, which consisted of Bie-
brich Scarlet-acid Fuchsin (5-10 minutes), 5% tung-
stophosphoric acid solution (5 minutes), and aniline blue
solution (5 minutes). Sections were washed in 1% acetic
acid (1 minute) and dehydrated with alcohol (twice for 5
minutes) and xylene (twice for 10 minutes) using standard
procedures.
Terminal deoxynucleotide transferase-mediated
deoxy uridine triphosphate nick-end labeling assays.
Cell death in the artery sections was evaluated using the
terminal deoxynucleotide transferase-mediated deoxy uri-
dine triphosphate nick-end labeling (TUNEL) assay kit
with Converter-POD according to the manufacturer’s
directions (Roche Inc, Basel, Switzerland). The sections
were dewaxed, washed twice in PBS (pH 7.4) for 3 minutes,
permeabilized with proteinase K for 8 minutes, and washed
again in PBS. Then the sections were incubated in the
TUNEL reaction mixture for 1.5 hours, followed by incu-
bation in Converter-POD for 30 minutes at 37C. After
washing in PBS, the signal-converted sections were devel-
oped using diaminobenzidine substrate and counterstained
Fig 1. Gross morphology and incidence of abdominal aortic aneurysms (AAAs). Representative photographs show
aortas of (A) control mice, without AAAs, and the macroscopic features of AAAs (arrow) induced by (B) angiotensin
(Ang) II, (C) 3,4-benzopyrene (BaP), and (D) Ang II plus BaP. No animals infused with medium-chain triglycerides
or BaP developed aneurysms. E, Ang II-induced AAA size was markedly increased in mice receiving BaP. +P < .01 vs
control group; -P < .05 vs Ang II group;;P < .01 vs BaP group. F, Incidence of aneurysms expressed as percentage
of animals in Ang II and Ang II/BaP group. The incidence of aneurysm was markedly increased in the Ang II/BaP
group compared with the Ang II group. -P < .05 Ang II/BaP vs Ang II group. The error bars show the standard error
of the mean.
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cells was calculated from six different ﬁelds from each artery.
Statistical analysis. Results are expressed as mean 6
standard error of themean.Differences between themultiple
groups were analyzed by one-way analysis of variance,
followed by the Bonferroni t-test. Values of P < .05 were
considered signiﬁcant.
RESULTS
BaP increased the incidence of aneurysms in Ang
II-infused mice. After 5 weeks of intraperitoneal injection
of medium-chain triglycerides, Ang II alone, BaP alone, or
Ang II plus BaP, animals were euthanized. Aortas were
removed and examined. Representative photographs of
aortas are shown in Fig 1,A-D. Compared with the control,
infusion of Ang II for 5 weeks signiﬁcantly increased the
abdominal aorta diameter, which was further increased
when BaP was coadministered (Fig 1,D). Quantiﬁcation of
aneurysm formation is shown in Fig 1, F. AAAs were present
in only 25% of mice infused with Ang II but were present in
42% of the mice that received Ang II/BaP (P < .05).Moreover, one animal in the Ang II/BaP group died of
rupture of the AAA. As expected, no AAAs developed in
mice in the control group. In addition, no AAAs developed
in mice receiving BaP alone, albeit these mice had a greater
aorta diameter.
BaP exacerbates aneurysms in Ang II-infused
mice. Masson staining was used to detect the presence of
collagen in the artery. Representative photomicrographs
of aortas from these animals are shown in Fig 2, A-D.
Mainly blue was observed in the control animals, indicating
the presence of collagen. However, red was observed in
animals receiving Ang II/BaP, indicating loss of collagen
and the presence of muscular ﬁber.
Hematoxylin and eosin staining of representative AAA
sections revealed disorganization of elastic ﬁbers within the
media in Ang II, BaP, and Ang II/BaP groups. In compar-
ison, the aortic media remained intact and well organized
in the control group (Fig 2, E-H). Vascular macrophage
inﬁltration contributes to the development of various
vascular diseases, including Ang II-induced AAA. Indeed,
immunohistochemistry showed prominent macrophage
Fig 2. Angiotensin (Ang) II-induced collage loss, vascular disorganization, and macrophage inﬁltration were promi-
nently increased in mice receiving coadministration of 3,4-benzopyrene (BaP). Abdominal aortic tissues were harvested,
and transversal sections were prepared and stained as described. Representative photomicrographs (original
magniﬁcation, 40) are shown from (A, E, I) control animals and animals treated with (B, F, J) Ang II, (C, G, K)
BaP, or (D, H, L) Ang II/BaP. A-D,Masson staining. E-H, Hematoxylin and eosin (HE) staining. I-L,Macrophage
inﬁltration.
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which was further promoted by BaP (Fig 2, I-L).
Immunostaining. MMPs, especially MMP-2, MMP-
9, and MMP-12, are thought to play a critical role in AAA
formation.22 Because BaP may regulate MMP activity,15
we examined MMP expression in abdominal aortic tissue
by immunostaining. Ang II infusion signiﬁcantly increased
MMP-2, MMP-9, and MMP-12 expression compared with
the control group, which was further increased by BaP
(Fig 3, A-L; Fig 4, B-D for quantitative analysis of the
result).
Immunochemistry staining was also used to evaluate
expression of NF-kB. Representative photomicrographs
of aortas from these animals are shown in Fig 3, M-P and
in Fig 2, I-L (Fig 4, D shows the quantitative analysis of
the result). Stronger staining for NF-kB was observed in
animals receiving Ang II/BaP compared with animals
receiving Ang II or BaP.
Apoptosis. Animals in the Ang II group had more
TUNEL-positive cells in the aortic media than animals in
the control group (Fig 3, Q-T; see Fig 4, E for quantitative
analysis of the result). In animals receiving Ang II/BaP,
average TUNEL-positive cell number was 30 6 12,signiﬁcantly more than those in animals receiving Ang II
(19 6 5; P < .05) or BaP (23 6 4; P < .05). Finally,
average TUNEL-positive cell number was 4 6 2 in the
control animals, signiﬁcantly less than any other group
(P < .01).
DISCUSSION
BaP is a signiﬁcant component of cigarette smoke.9 In
this study, we used old C57/B6n mice (7 to 9 months old)
as an animal model to examine the inﬂuence of BaP on
AAA formation and the mechanisms by which BaP exerts
its inﬂuence. We used C57/B6n mice, instead of apolipo-
protein Ee/e mice, because the incidence of AAA forma-
tion in C57/B6n is w20% when the mice are treated
with the indicated dose of Ang II, which would give us
the room to examine the effect of BaP. We demonstrate
in this study that BaP indeed promotes the formation of
AAA in Ang II-treated mice, and furthermore, that the
increased incidence of the AAA formation in the BaP/
Ang II-treated animals occurs concomitantly with incre-
ment of macrophage inﬁltration, activation of NF-kB,
expression of MMP-2, MMP-9, and MMP-12, as well as
augmented apoptosis of VSMCs. Our study sheds new
Fig 3. Angiotensin (Ang) II-induced expression of matrix metalloproteinases (MMPs), nuclear factor (NF)-kB, and
apoptosis were prominently increased in mice receiving coadministration of 3,4-benzopyrene (BaP). Abdominal aortic
tissues were harvested, and transversal sections were prepared and stained as described. Representative photomicro-
graphs are shown from (A, E, I, M, Q) control animals and animals treated with (B, F, J, N, R) Ang II, (C, G, K, O, S)
BaP, or (D, H, L, P, T) Ang II/BaP. A-D, MMP-2 (original magniﬁcation, 40). E-H, MMP-9 (original
magniﬁcation, 40). I-L, MMP-12 (original magniﬁcation, 40). M-P, NF-kB (original magniﬁcation, 40). Q-T,
Apoptosis (original magniﬁcation, 20). See Fig 4 for quantitative analysis of the result.
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of AAA.
The formation of AAA is a chronic process. Patholog-
ically, AAA is characterized by inﬁltration of inﬂammatory
cells, degeneration of elastic-collagenic ﬁber, decreased
number of VSMCs, and overexpression of MMPs.2-6
Normal arterial wall is composed of endothelial cells,
VSMCs, and extracellular matrix (ECM) proteins arranged
in three concentric layers: intima, media, and adventitia.ECM proteins are secreted mostly by VSMCs and assem-
bled into an organized meshwork in close association
with the surface of the cells that create them. During
AAA formation, inﬁltration and accumulation of inﬂamma-
tory cells in arterial wall is the ﬁrst step, followed by the
degeneration of ECM and loss of VSMCs in media, which
results in the disruption of elastic lamella and deterioration
of collagen networks.15,22 Weakening of the arterial
wall leads to dilation of the affected artery. As the disease
Fig 4. Densitometric quantiﬁcation of expression of (A)matrix metalloproteinase (MMP)-2, (B)MMP-9, (C)MMP-12,
(D) nuclear factor (NF)-kB, and (E) apoptosis in the control group and in animals treated with angiotensin (Ang) II,
3,4-benzopyrene (BaP), or Ang II and BaP combined (n ¼ 12 per group). +P < .01 vs control group; :P < .01 and
-P < .05 vs Ang II group;;P < .01 and CP < .05 vs BaP group. The error bars show the standard error of the mean.
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wall, and thrombosis and vessel rupture may occur.23
Although other inﬂammatory cells such as T and B cells
were seen in the tissue samples of AAAs and might play
roles in AAAs,24 inﬁltration and accumulation of macro-
phages was very prominent in the development of AAAs.
Because of the scarcity of human samples of AAAs in the
early stages, data showing the macrophage inﬁltration
into human arterial wall were mostly from the biopsy spec-
imens of AAAs at late stages.25,26 However, the inﬁltration
of macrophages at early stages has been clearly shown in
animal studies.5,26 These data suggest that macrophages
participate in the entire process of AAA development
from initiation, to expansion, and to eventual rupture of
the AAA. The results of this study clearly show that BaP
increases the inﬁltration of macrophages in aortic wall,which no doubt contributes to the development of AAAs
in BaP/Ang II-treated mice.
The degeneration of collagen and elastin in AAA is the
result of reduced production and elevated degradation of
ECM. Increasing MMP activities are regarded as the major
cause of the degradation of the ECM proteins in the arte-
rial wall. Excessive expression of MMPs, such as MMP-1,
MMP-2, MMP-9, MMP-12, and MMP-13, has been
observed in AAA tissue samples.27-30 The expression deﬁ-
ciency of MMP-2, MMP-12, or MMP-9 prevents the
occurrence of AAA. Induced expression of MMPs by BaP
may be directly involved in the development of aneurysmal
disease in smokers. To address this important issue, we
examined the effects of BaP on Ang II-induced AAA
formation in mice. In apolipoprotein Ee/e (hyperlipi-
demic) male mice, infusion of Ang II for 4 weeks results
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the high rate of Ang II-induced AAA formation in the
apolipoprotein Ee/e male mice leaves little room for the
evaluation of additional risk factor, we used a modiﬁed
model that uses C57/B6n mice and a lower dose of Ang
II, which develops AAAs at much lower frequency. In
mice receiving BaP alone, no AAA formation was observed
and vascular tunica adventitia and thickness of blood vessel
wall were almost normal, but there was inﬁltration of
macrophages and abnormal structure of the vascular media.
In this study, we observed the elevated expression of
MMP-2, MMP-9, and MMP-12 in the aortic wall of
BaP/Ang II-treated mice, which is another reason for
the increased AAA incidence in BaP/Ang II-treated
mice. Suppression of ECM protein expression from
VSMCs or loss of VSMCs in the media layer of artery could
also reduce production of ECM proteins.27-29 We have
observed an augmented apoptosis of VSMCs in the aortic
wall of BaP/Ang II-treated mice but not in BaP-treated
or Ang II-treated mice. This result indicates that somehow
BaP and Ang II could synergistically work on VSMCs and
cause apoptosis of the cells. The present study clearly
supports that BaP may play an important role in AAA
formation in smokers.
The proinﬂammatory transcription factor NF-kB has
an important effect in the development of AAA by regu-
lating macrophage migration and MMP activities. Rapamy-
cin and pyrrolidine dithiocarbamate signiﬁcantly reduced
the rate of aneurysm formation, and the reduction was
associated with suppression of NF-kB activity.31,32 Using
chimeric decoy oligodeoxynucleotides that simultaneously
inhibited NF-kB and ets (an essential transcription factor
for angiogenesis), Nakashima et al33 showed a signiﬁcant
inhibition of the progression of AAA, which is accompa-
nied by reduction of macrophage migration and of MMP
expression. In a more speciﬁc study, Chase et al34 showed
that adenovirus-mediated gene transfer of the inhibitory
NF-kB subunit, I-kBa, inhibited expression of MMP-9
and MMP-1 from human monocyte-derived macrophages
in vitro and expression of MMP-1 and MMP-3 from the
foam cells in vivo in cholesterol-fed rabbits.
NF-kB expression and activity are markedly upregu-
lated during inﬂammation. It is translocated from the
nucleus to the cytoplasm when cells are stimulated by
various inﬂammatory signals. In return, NF-kB may induce
the expression of inﬂammatory genes in addition to attrac-
tants, adhesion molecules, and MMPs, which are respon-
sible for the activation, proliferation, and inﬁltration of
macrophages and mononuclear cells. NF-kB may thus
play an important role in the pathogenesis of AAA. In
our study, we show that BaP activates NF-kB in the aortic
wall of the treated mice and that activation of NF-kB was
strongest in the Ang II/BaP group. Furthermore, there
was increased aortic macrophage inﬁltration and MMP-2
expression. These ﬁndings are consistent with previous
ﬁndings that inﬂammation, at least partly modulated by
NF-kB, may contribute to increased proteolytic activity
and aneurysm development. Taken together, these ﬁndingssuggest that BaP is an important component in cigarette
smoke that contributes to AAA formation.
CONCLUSIONS
We demonstrate here that BaP has a marked, deterio-
rating effect in Ang II-induced AAA. These ﬁndings
support the previous observation of the effect of cigarette
smoking on aortic aneurysmal disease and suggest an
important role for NF-kB in the pathogenesis of AAA in
this experimental model.
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